ALS drug developer Coya Therapeutics files for proposed $17M IPO (Pending:COYA)
2d illustrations and photos ALS drug developer Coya Therapeutics (COYA) has proposed to raise $17M through an initial public offering. Coya didn’t specify in its filing the number or price of the shares to be offered, but indicated in an attached filing fee schedule that it was seeking around $17M. The biotech company hopes to … Read more